Cargando…

Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: Can we stratify at-risk populations?

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a new nomenclature recently proposed by a panel of international experts so that the entity is defined based on positive criteria and linked to pathogenesis, replacing the traditional non-alcoholic fatty liver disease (NAFLD), a definit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fassio, Eduardo, Barreyro, Fernando J, Pérez, M Soledad, Dávila, Diana, Landeira, Graciela, Gualano, Gisela, Ruffillo, Gabriela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891669/ https://www.ncbi.nlm.nih.gov/pubmed/35317172 http://dx.doi.org/10.4254/wjh.v14.i2.354

Ejemplares similares

Liver transplantation for hepatocellular carcinoma: Where do we stand?
por: Santopaolo, Francesco, et al.
Publicado: (2019)

Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
por: Wong, Carrie R, et al.
Publicado: (2016)

Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma
por: Said, Adnan, et al.
Publicado: (2017)

Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge
por: Mattos, Ângelo Z, et al.
Publicado: (2021)

Biomarkers in anal cancer: from biological understanding to stratified treatment
por: Jones, Christopher M, et al.
Publicado: (2017)

Implications of metabolic dysfunction associated fatty liver disease in COVID-19
por: Chakraborty, Raja, et al.
Publicado: (2023)

Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
por: Meringer, Hadar, et al.
Publicado: (2019)

Predicting systemic spread in early colorectal cancer: Can we do better?
por: Brockmoeller, Scarlet Fiona, et al.
Publicado: (2019)

We and herbivores eat endophytes
por: Martínez‐Romero, Esperanza, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease-related hepatocellular carcinoma: Is there a role for immunotherapy?
por: Mattos, Ângelo Z, et al.
Publicado: (2022)

Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight
por: Vasques-Monteiro, Isabela Macedo Lopes, et al.
Publicado: (2021)

De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation
por: Han, Ma Ai Thanda, et al.
Publicado: (2021)

Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis
por: Pal, Shreya C, et al.
Publicado: (2023)

Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalities
por: da Fonseca, Leonardo Gomes, et al.
Publicado: (2022)

Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives
por: Ueno, Masayuki, et al.
Publicado: (2022)

2022 Monkeypox outbreak: Why is it a public health emergency of international concern? What can we do to control it?
por: Ren, Shi-Yan, et al.
Publicado: (2022)

Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma
por: Ocker, Matthias
Publicado: (2020)

Non-alcoholic fatty liver disease: Is surgery the best current option and can novel endoscopy play a role in the future?
por: Mandour, Mandour Omer, et al.
Publicado: (2022)

What ‘Omics can tell us about antifungal adaptation
por: Ribeiro, Gabriela Fior, et al.
Publicado: (2021)

Angiogenesis inhibitors in clinical development; where are we now and where are we going?
por: Eskens, F A L M
Publicado: (2004)

Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis
por: Tovo, Cristiane Valle, et al.
Publicado: (2023)

Immunity to SARS-CoV-2: What Do We Know and Should We Be Testing for It?
por: Misra, Anisha, et al.
Publicado: (2022)

Diabetes and fatty liver: Involvement of incretin and its benefit for fatty liver management
por: Wibawa, I Dewa Nyoman, et al.
Publicado: (2023)

Robotic donor hepatectomy: Are we there yet?
por: Rammohan, Ashwin, et al.
Publicado: (2021)

Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?
por: Devi, Jalpa, et al.
Publicado: (2022)

Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do
por: Sanchez-Torrijos, Yolanda, et al.
Publicado: (2017)

Assessing the prognosis of cirrhotic patients in the intensive care unit: What we know and what we need to know better
por: da Silveira, Fernando, et al.
Publicado: (2021)

Waste lipids to energy: how to optimize methane production from long‐chain fatty acids (LCFA)
por: Alves, M. Madalena, et al.
Publicado: (2009)

Non-alcoholic fatty liver disease
por: Neuschwander-Tetri, Brent A.
Publicado: (2017)

Nutritional therapy for hepatocellular carcinoma
por: Ruiz-Margáin, Astrid, et al.
Publicado: (2021)

Immunotherapy for recurrent hepatocellular carcinoma
por: Bhatt, Ahan, et al.
Publicado: (2023)

What We Know Currently about Mirror Neurons
por: Kilner, J.M., et al.
Publicado: (2013)

Management of refractory ascites in cirrhosis: Are we out of date?
por: Annamalai, Alagappan, et al.
Publicado: (2016)

Sessile serrated adenoma/polyps: Where are we at in 2016?
por: Singh, Rajvinder, et al.
Publicado: (2016)

Thrombocytopenia after liver transplantation: Should we care?
por: Takahashi, Kazuhiro, et al.
Publicado: (2018)

Critically ill patients and gut motility: Are we addressing it?
por: Vazquez-Sandoval, Alfredo, et al.
Publicado: (2017)

Endoscopic ultrasound-guided biliary drainage: Are we there yet?
por: Pawa, Rishi, et al.
Publicado: (2021)

Marine polyunsaturated fatty acids and cancer therapy
por: Vaughan, V C, et al.
Publicado: (2013)

Mediterranean diet and nonalcoholic fatty liver disease
por: Anania, Caterina, et al.
Publicado: (2018)

Fatty liver and celiac disease: Why worry?
por: Narciso-Schiavon, Janaina Luz, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qg6jquruf3i4gec975uf16l3qh